Istituto Nazionale Tumori Fondazione G. Pascale di Napoli Strutturadi Oncologia

Naples 80131

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic NSCLC, Non-Small Cell Lung Cancer

Studies at this site

• Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02) — Running, not enrolling
• Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) — Completed